PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
27-Nov-2020 Resolutions at the Extraordinary General Meeting in BioInvent on November 27, 2020 BioInvent
27-Nov-2020 Nanoform launches technology for biologics and sets new near-term business target for 2021 Nanoform
27-Nov-2020 Haoma Medica Completes First-in-Human Trial for NaQuinate, a Novel Treatment in Development for Osteoporosis Haoma Medica
26-Nov-2020 Haoma Medica Completes First-in-Human Trial for NaQuinate, a Novel Treatment in Development for Osteoporosis Haoma Medica
26-Nov-2020 UK TECH SPINOUT SALIENT BIO LAUNCHES FASTEST EVER ROBOTIC COVID-19 PCR-BASED TESTS WITH A GOLD STANDARD ACCURACY OF OVER 99% Salient Bio
26-Nov-2020 Aqilion presents Nomination Committee for the 2021 Annual General Meeting Aqilion
26-Nov-2020 Pharming Group Publicly Files Registration Statement with the U.S. SEC to Facilitate Listing of ADSs Representing Ordinary Shares on Nasdaq Global Market Pharming Group N.V.
25-Nov-2020 Amgen To Present At The Evercore ISI Virtual HealthCONx Conference Amgen
25-Nov-2020 DTx Pharma to Present at Several Upcoming Virtual Events DTx Pharma
25-Nov-2020 Moderna Announces the European Commission’s Approval of Advance Purchase Agreement for Initial 80 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273) Moderna
25-Nov-2020 CytoSorbents Highlights Largest Published Case Series To Date Using CytoSorb in Critically Ill COVID-19 Patients CytoSorbents Corporation
25-Nov-2020 Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Sierra Oncology
25-Nov-2020 Plan France Relance : les Pôles Santé en réseau formulent trois propositions pour assurer la souveraineté sanitaire de la France Andrew Lloyd Associates
25-Nov-2020 TargED closes seed investment and partners with UMC Utrecht for the development of Microlyse - a next-generation thrombolytic clot-busting drug TargED Biopharmaceuticals
25-Nov-2020 RhoVac's Prostate Cancer Drug Candidate, RV001, is granted Fast Track Designation by the FDA RhoVac
24-Nov-2020 Lilly to Participate in Evercore ISI 3rd Annual HealthCONx Conference Eli Lilly and Company
24-Nov-2020 Celularity Announces Dosing of First Patient in Phase I Study of Human Placental Hematopoietic Stem Cell-Derived Natural Killer Cells (CYNK-001) in Adults with Recurrent Glioblastoma Multiforme (GBM) and E-Poster Presentation at the Society for Neuro-Oncology (SNO) 2020 Virtual Meeting Celularity, Inc.
24-Nov-2020 Elevian Announces $15 Million Equity Financing Elevian, Inc.
24-Nov-2020 OliPass Announces Formation of Scientific Advisory Board of Pioneers in Sodium Ion Channellopathy and Pain OliPass Corporation
24-Nov-2020 Creative BioMart Supports Immunology Study with a Wide Selection of Adaptive Immunity Proteins Creative BioMart